Mars, Incorporated has successfully finalized the acquisition of Cerba HealthCare’s interests in Cerba Vet and ANTAGENE, integrating them into Mars Petcare’s Science & Diagnostics division. This strategic move enhances Mars’ capabilities in veterinary diagnostics, complementing existing entities like Antech and Wisdom Panel.
Nefertiti Greene, President of Mars Science & Diagnostics, expressed enthusiasm about the collaboration, highlighting the alignment with Mars Petcare’s mission to enhance pet welfare globally.
Mars, Incorporated, a family-owned business with a $50 billion portfolio, is renowned for brands such as ROYAL CANIN®, PEDIGREE®, and M&M’s®. Their commitment to sustainability and quality underpins operations across pet care, food products, and veterinary services.
For further details on Mars, visit www.mars.com. Connect on social media via Facebook, Instagram, LinkedIn, and YouTube.
For more on Mars Science & Diagnostics, which leverages leading pet health science and diagnostics, visit their divisional page.
